COVID-19 and Cystic Fibrosis: Diagnostic Difficulties or Incorrect Methods?

被引：1

作者：

Pecho-Silva, Samuel ^{[1
,2
]}

Navarro-Solsol, Ana Claudia ^{[3
]}

Panduro-Correa, Vicky ^{[4
]}

Arteaga-Livias, Kovy ^{[2
,4
]}

Rodriguez-Morales, Alfonso J. ^{[2
,5
,6
]}

Dhama, Kuldeep ^{[7
]}

机构：

[1] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru

[2] Univ Cient Sur, Lima, Peru

[3] Univ Nacl Ucayali, Pucallpa, Peru

[4] Univ Nacl Hermilio Valdizan, Fac Med, Huanuco, Peru

[5] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia

[6] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira 660004, Risaralda, Colombia

[7] ICAR Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India

来源：

JOURNAL OF PURE AND APPLIED MICROBIOLOGY | 2020年 / 14卷 / 03期

关键词：

Cystic fibrosis; COVID-19; SARS-CoV-2; Serological tests; pandemic; Peru; Latin America; EXACERBATIONS; IMPACT; CARE;

D O I：

10.22207/JPAM.14.3.06

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Cystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic.

引用

页码：1681 / 1685

页数：5

共 50 条

[1] Cystic Fibrosis and COVID-19
Chapman, Kyle D.
Moffett, Kathryn S.
[J]. SOUTHERN MEDICAL JOURNAL, 2020, 113 (09) : 422 - 422
[2] Diagnostic difficulties in cystic fibrosis
Pérez-Aguilar, F
[J]. REVISTA CLINICA ESPANOLA, 1999, 199 (12): : 820 - 824
[3] The Impact of COVID-19 in Cystic Fibrosis
Flume, Patrick A.
Saiman, Lisa
Marshall, Bruce
[J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (06): : 466 - 468
[4] Impact of COVID-19 on people with cystic fibrosis
Colombo, Carla
Burgel, Pierre-Regis
Gartner, Silvia
van Koningsbruggen-Rietschel, Silke
Naehrlich, Lutz
Sermet-Gaudelus, Isabelle
Southern, Kevin W.
[J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (05): : E35 - E36
[5] Cystic fibrosis telemedicine in the era of COVID-19
Rad, Elika J.
Mirza, Alicia A.
Chhatwani, Laveena
Purington, Natasha
Mohabir, Paul K.
[J]. JAMIA OPEN, 2022, 5 (01)
[6] Cystic fibrosis and COVID-19: Care considerations
Mirza, Alicia A.
Rad, Elika J.
Mohabir, Paul K.
[J]. RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
[7] COVID-19 outcomes in people with cystic fibrosis
Burgel, Pierre-Regis
Goss, Christopher
[J]. CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (06) : 538 - 543
[8] Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic
Dowd, Christopher
Van Citters, Aricca D.
Dieni, Olivia
Willis, Anne
Powell, Leslie
Sabadosa, Kathryn A.
[J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 : S3 - S8
[9] The optimal diagnostic methods for COVID-19
Harahwa, Tinotenda A.
Yau, Thomas Ho Lai
Lim-Cooke, Mae-Sing
Al-Haddi, Salah
Zeinah, Mohamed
Harky, Amer
[J]. DIAGNOSIS, 2020, 7 (04) : 349 - 356
[10] Asymptomatic case of Covid-19 in an infant with cystic fibrosis
Poli, Piercarlo
Timpano, Silviana
Goffredo, Martina
Padoan, Rita
Badolato, Raffaele
[J]. JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : E18 - E18

← 1 2 3 4 5 →